Bulletin
Investor Alert

New York Markets Close in:

Tilray Inc. Cl 2

NAS: TLRY

GO
/marketstate/country/us

Market open

 --Real time quotes

Nov 23, 2020, 11:45 a.m.

/zigman2/quotes/209129655/composite

$

6.94

Change

-0.42 -5.71%

Volume

Volume 13.74m

Real time quotes

/zigman2/quotes/209129655/composite

Previous close

$ 7.36

$ 6.94

Change

-0.42 -5.71%

Day low

Day high

$6.78

$7.35

Open

52 week low

52 week high

$2.43

$22.95

Open

Company Description

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extract...

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Valuation

Price to Sales Ratio

10.31

Price to Book Ratio

6.17

Enterprise Value to Sales

12.54

Total Debt to Enterprise Value

0.22

Efficiency

Revenue/Employee

101,445.00

Income Per Employee

-195,121.00

Receivables Turnover

5.52

Total Asset Turnover

0.22

Liquidity

Current Ratio

2.80

Quick Ratio

1.85

Cash Ratio

1.05

Profitability

Gross Margin

-21.02

Operating Margin

-129.69

Pretax Margin

-194.70

Net Margin

-192.34

Return on Assets

-41.36

Return on Equity

-133.01

Return on Total Capital

-31.36

Return on Invested Capital

-46.66

Capital Structure

Total Debt to Total Equity

164.46

Total Debt to Total Capital

62.19

Total Debt to Total Assets

52.34

Long-Term Debt to Equity

163.07

Long-Term Debt to Total Capital

61.66

Officers and Executives

Name Age Officer Since Title
Mr. Brendan Kennedy 46 2018 President, Chief Executive Officer & Director
Mr. Jon Levin 50 2020 Chief Operating Officer
Mr. Michael Kruteck 57 2020 Chief Financial Officer
Dr. Joshua Eades - 2014 Chief Science Officer & Vice President
Mr. Mark Castaneda 54 2018 Chief Financial Officer & Treasurer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
11/10/2020 Brendan Kennedy
President and CEO; Director
380,781   Derivative/Non-derivative trans. at $7.76 per share. 2,954,860
11/06/2020 Brendan Kennedy
President and CEO; Director
2,127   Disposition at $11.71 per share. 24,907
11/06/2020 Brendan Kennedy
President and CEO; Director
118,852   Disposition at $10.72 per share. 1,274,093
11/06/2020 Brendan Kennedy
President and CEO; Director
148,933   Disposition at $9.96 per share. 1,483,372
11/06/2020 Brendan Kennedy
President and CEO; Director
130,088   Disposition at $9 per share. 1,170,792
11/06/2020 Christine Thompson St. Clare
Director
4,400   Disposition at $10.05 per share. 44,220
11/06/2020 Rebekah Dopp
Director
4,812   Disposition at $10 per share. 48,120
11/05/2020 Brendan Kennedy
President and CEO; Director
127,213   Disposition at $7.76 per share. 987,172
11/05/2020 Brendan Kennedy
President and CEO; Director
272,787   Disposition at $7.28 per share. 1,985,889
11/04/2020 Brendan Kennedy
President and CEO; Director
400,000   Disposition at $6.04 per share. 2,416,000
10/15/2020 Brendan Kennedy
President and CEO; Director
400,000   Disposition at $5.61 per share. 2,244,000
10/14/2020 Brendan Kennedy
President and CEO; Director
400,000   Disposition at $5.83 per share. 2,332,000
10/01/2020 Brendan Kennedy
President and CEO; Director
11,415   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2020 Edward Wood Pastorius
Chief Revenue Officer
1,812   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2020 Brendan Kennedy
President and CEO; Director
46,875   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2020 Michael Shtender-Auerbach
Director
2,188   Derivative/Non-derivative trans. at $0 per share. 0
10/01/2020 Edward Wood Pastorius
Chief Revenue Officer
6,250   Derivative/Non-derivative trans. at $0 per share. 0
09/30/2020 Brendan Kennedy
President and CEO; Director
158,746   Derivative/Non-derivative trans. at $0 per share. 0
09/30/2020 Brendan Kennedy
President and CEO; Director
8,252,161   Derivative/Non-derivative trans. at $0 per share. 0
09/30/2020 Maryscott Greenwood
Director
15,383   Derivative/Non-derivative trans. at $0 per share. 0
09/30/2020 Maryscott Greenwood
Director
15,313   Derivative/Non-derivative trans. at $0 per share. 0
09/22/2020 Brendan Kennedy
President and CEO; Director
500,000   Disposition at $5.13 per share. 2,565,000
09/22/2020 Brendan Kennedy
President and CEO; Director
500,000   Derivative/Non-derivative trans. at $0 per share. 0
09/21/2020 Brendan Kennedy
President and CEO; Director
500,000   Disposition at $5.01 per share. 2,505,000
09/21/2020 Brendan Kennedy
President and CEO; Director
117,244   Derivative/Non-derivative trans. at $0 per share. 0
/news/latest/company/us/tlry

MarketWatch News on TLRY

  1. Tilray Inc. Cl 2 stock outperforms market on strong trading day

    5:38 p.m. Nov. 20, 2020

    - MarketWatch Automation

  2. Tilray Inc. Cl 2 stock falls Thursday, underperforms market

    5:38 p.m. Nov. 19, 2020

    - MarketWatch Automation

  3. Tilray Inc. Cl 2 stock falls Wednesday, underperforms market

    5:38 p.m. Nov. 18, 2020

    - MarketWatch Automation

  4. Tilray Inc. Cl 2 stock falls Tuesday, underperforms market

    5:38 p.m. Nov. 17, 2020

    - MarketWatch Automation

  5. Tilray Inc. Cl 2 stock falls Monday, underperforms market

    5:38 p.m. Nov. 16, 2020

    - MarketWatch Automation

  6. Canopy Growth Corp. stock outperforms market on strong trading day

    8:08 p.m. Nov. 13, 2020

    - MarketWatch Automation

  7. Tilray Inc. Cl 2 stock outperforms market on strong trading day

    5:38 p.m. Nov. 13, 2020

    - MarketWatch Automation

  8. Canopy Growth Corp. stock falls Thursday, underperforms market

    8:09 p.m. Nov. 12, 2020

    - MarketWatch Automation

  9. Tilray Inc. Cl 2 stock falls Thursday, underperforms market

    5:38 p.m. Nov. 12, 2020

    - MarketWatch Automation

  10. Tilray downgraded to sell from hold at Stifel Nicolaus

    9:09 a.m. Nov. 11, 2020

    - Tomi Kilgore

  11. Tilray stock price target raised to $8.50 from $6.00 at MKM Partners

    11:00 a.m. Nov. 10, 2020

    - Tomi Kilgore

  12. Tilray stock price target raised to C$10 from C$9 at Alliance Global Partners

    7:15 a.m. Nov. 10, 2020

    - Tomi Kilgore

  13. Tilray shares up 23% premarket

    6:09 a.m. Nov. 5, 2020

    - Ciara Linnane

  14. Loading more headlines...
/news/nonmarketwatch/company/us/tlry

Other News on TLRY

  1. Tilray to exchange $124.3M convertible senior notes for common stock

    10:07 a.m. Today

    - Seeking Alpha

  2. Stocks To Watch: Eyes On Best Buy, Vaccines And Holiday Cheer

    8:41 a.m. Nov. 21, 2020

    - Seeking Alpha

  3. US Indexes Close With Losses Friday

    3:43 p.m. Nov. 20, 2020

    - GuruFocus.com

  4. Why the Bull Run in Canopy Growth Will Last

    8:23 a.m. Nov. 20, 2020

    - InvestorPlace.com

  5. Tilray: Will Raise Money Diluting Shares Sending Stock Lower

    10:02 p.m. Nov. 19, 2020

    - Seeking Alpha

  6. US Indexes End Higher Thursday

    3:57 p.m. Nov. 19, 2020

    - GuruFocus.com

  7. Coronavirus May Lend a Helping Hand to Tilray Shares

    6:42 a.m. Nov. 19, 2020

    - InvestorPlace.com

  8. Stock Selection Matters (Podcast)

    8:00 a.m. Nov. 18, 2020

    - Seeking Alpha

  9. How to Safely Play the Breakout in Fisker Stock

    6:21 a.m. Nov. 17, 2020

    - InvestorPlace.com

  10. Politics Still Holds the Key to Tilray Cannabis

    8:28 a.m. Nov. 12, 2020

    - InvestorPlace.com

  11. TLRY Stock: Voters in January Will Decide if Tilray Goes to $95 or $0

    8:28 a.m. Nov. 12, 2020

    - InvestorPlace.com

  12. Canopy Growth Stock Is a Leader in a Budding Industry

    2:07 p.m. Nov. 11, 2020

    - InvestorPlace.com

  13. Could a ‘Green Wave’ Finally Lift Aphria Out of Its Funk?

    1:20 p.m. Nov. 11, 2020

    - InvestorPlace.com

  14. Tilray down 5% on post-earnings downgrade to Sell

    7:27 a.m. Nov. 11, 2020

    - Seeking Alpha

  15. Oppenheimer Keeps a Hold Rating on Tilray (TLRY)

    4:42 p.m. Nov. 10, 2020

    - SmarterAnalyst

  16. Tilray Q3: Another Miserable Result

    1:20 p.m. Nov. 10, 2020

    - Seeking Alpha

  17. US Indexes End Mostly Higher Monday

    8:50 a.m. Nov. 10, 2020

    - GuruFocus.com

  18. Beyond Meat, Penumbra leads premarket losers' pack

    8:48 a.m. Nov. 10, 2020

    - Seeking Alpha

  19. Loading more headlines...

At a Glance

Tilray, Inc.

1100 Maughan Road

Nanaimo, British Columbia V9X IJ2

Phone

1 8448457291

Industry

Farming

Sector

Agriculture

Fiscal Year-end

12/2020

Revenue

$166.98M

Net Income

$-321.17M

2019 Sales Growth

287.2%

Employees

1,646

/news/pressrelease/company/us/tlry

Press Releases on TLRY

  1. Tilray, Inc. Reports 2020 Third Quarter Results

    4:06 p.m. Nov. 9, 2020

    - BusinessWire - BZX

  2. Tilray, Inc. to Host Earnings Call

    3:16 p.m. Nov. 9, 2020

    - ACCESSWIRE

  3. Friday's ETF with Unusual Volume: SPGM

    12:07 p.m. Nov. 6, 2020

    - MarketNewsVideo.com

  4. Medical Cannabis Legalization Helps Destigmatize Related Products

    9:49 a.m. Oct. 5, 2020

    - PR Newswire - PRF

  5. Loading more headlines...
Link to MarketWatch's Slice.